Antimicrobial susceptibility profiling and genomic diversity of multidrug-resistant acinetobacter baumannii isolates from a teaching hospital in Malaysia

Japanese Journal of Infectious Diseases

Volumn 64, Issue 4, 2011, Pages 337-340

  Kong, Boon Hong ^a,b   Hanifah, Yasmin Abu ^b   Yusof, Mohd Yasim Mohd ^b   Thong, Kwai Lin ^a,b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOPERAZONE; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULPERAZON; SULTAMICILLIN;

ACINETOBACTER BAUMANNII; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CLUSTER ANALYSIS; CONTROLLED STUDY; ENVIRONMENT; GENETIC VARIABILITY; GENOMICS; HAND; HEALTH CARE PERSONNEL; INTENSIVE CARE UNIT; MALAYSIA; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; TEACHING HOSPITAL;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BETA-LACTAMS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENDEMIC DISEASES; ENVIRONMENTAL MICROBIOLOGY; FOMITES; GENOME, BACTERIAL; HAND; HOSPITALS; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; INTENSIVE CARE UNITS; MALAYSIA; MICROBIAL SENSITIVITY TESTS; POLYMYXIN B;

EID: 79960989382     PISSN: 13446304     EISSN: 18842836     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Bergogne-Berezin, E. and Towner, K.J. (1996): Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin. Microbiol. Rev., 9, 148-165.
2. Institute for Medical Research, Ministry of Health, Malaysia. National Surveillance on Antibiotic Resistance Report for Year 2002-2005. Online at . Accessed 23 September 2010.
3. Smolyakov, R., Borera, K., Riesenberga, K., et al. (2003): Nosocomial multi-drug resistant Acinetobacter baumannii bloodstream infection: risk factors and outcome with ampicillin-sulbactam treatment. J. Hosp. Infect., 54, 32-38.
4. Coelho, J., Woodford, N., Turton, J., et al. (2004): Multiresistant Acinetobacter in the UK: how big a threat? J. Hosp. Infect., 58, 167-169.
5. Webster, C., Towner, K.J. and Humphreys, H. (2000): Survival of Acinetobacter on three clinically related inanimate surfaces. Infect. Control. Hosp. Epidemiol., 21, 246-246.
6. D'Agata, E.M., Thayer, V. and Schaffner, W. (2000): An outbreak of Acinetobacter baumannii: the importance of cross-transmission. Infect. Control. Hosp. Epidemiol., 21, 588-591.
7. Seifert, H. and Gernier-Smidt, P. (1995): Comparison of ribotyping and pulsed-field gel electrophoresis for molecular typing of Acinetobacter isolates. J. Clin. Microbiol., 33, 1402-1407.
8. Dijkshoorn, L., van Harsselaar, B., Tjernberg, I., et al. (1998): Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst. Appl. Microbiol., 21, 33-39.
9. Clinical and Laboratory Standards Institute (2007): Performance standards for antimicrobial disk susceptibility testing; 17th informational supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute, Wayne, Pa.
10. Seifert, H., Dolzani, L., Bressan, R., et al. (2005): Standardization and interlaboratory reproducibility assessment of pulsedfield gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J. Clin. Microbiol., 43, 4328-4335.
11. van Belkum, A., Tassios, P.T., Dijkshoorn, L., et al. (2007): Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin. Microbiol. Infect. Dis., 13, 1-46.
12. Misbah, S., Abu Bakar, S., Hassan, H., et al. (2004): Antibiotic susceptibility and REP-PCR fingerprints of Acinetobacter spp. isolated from a hospital ten years apart. J. Hosp. Infect., 58, 254-261.
13. Falagas, M.E., Mourtzoukou, E.G., Polemis, M., et al. (2007): Trends in antimicrobial resistance of Acinetobacter baumannii clinical isolates from hospitalized patients in Greece and treatment implications. Clin. Microbiol. Infect., 13, 816-819.
14. Tan, T.Y., Hsu, L.Y., Koh, T.H., et al. (2008): Antibiotic resistance in gram-negative bacilli: a Singapore perspective. Ann. Acad. Med. Singapore, 37, 819-825.
15. Williams, J.D. (1999): Beta-lactamases and beta-lactamase inhibitors. Int. J. Antimicrob. Agents, 12, 3-7.
16. Ballow, C.H. and Schentag, J.J. (1992): Trends in antibiotic utilization and bacterial resistance: report of the National Nosocomial Resistance Surveillance Group. Diagn. Microbial. Infect. Dis., 15, 37S-42S.
17. Choi, J.Y., Kim, C.O., Park, Y.S., et al. (2006): Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia. Yonsei Med. J., 47, 63-69.
18. Urban, C., Mariano, N., Rahal, J.J., et al. (2001): Polymyxin Bresistant Acinetobacter baumannii clinical isolate susceptible to recombinant BPI21 and Cecropin P1. Antimicrob. Agents Chemother., 45, 994-995.
19. Ko, K.S., Suh, J.Y., Kwon, K.T., et al. (2007): High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother., 60, 1163-1167.
20. Wang, S.H., Sheng, W.H., Chang, Y.Y., et al. (2003): Healthcare-associated outbreak due to pan-drug resistant Acinetobacter baumannii in a surgical intensive care unit. J. Hosp. Infect., 53, 97-102.